$3.38 Billion is the total value of Casdin Capital, LLC's 52 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 42.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NVTA | Buy | INVITAE CORP | $514,181,000 | +31.3% | 12,298,038 | +36.1% | 15.23% | -13.1% |
| BLFS | Buy | BIOLIFE SOLUTIONS INC | $296,786,000 | +75.6% | 7,440,107 | +27.4% | 8.79% | +16.2% |
| FATE | FATE THERAPEUTICS INC | $277,337,000 | +127.5% | 3,050,000 | 0.0% | 8.22% | +50.5% | |
| EXAS | New | EXACT SCIENCES CORP | $196,767,000 | – | 1,485,149 | +100.0% | 5.83% | – |
| BPMC | BLUEPRINT MEDICINES CORP | $173,833,000 | +21.0% | 1,550,000 | 0.0% | 5.15% | -20.0% | |
| RLAY | RELAY THERAPEUTICS INC | $158,298,000 | -2.4% | 3,808,894 | 0.0% | 4.69% | -35.4% | |
| TWST | TWIST BIOSCIENCE CORP | $141,290,000 | +86.0% | 1,000,000 | 0.0% | 4.19% | +23.0% | |
| PACB | Buy | PACIFIC BIOSCIENCES CALIF IN | $129,700,000 | +192.0% | 5,000,000 | +11.1% | 3.84% | +93.2% |
| DNLI | DENALI THERAPEUTICS INC | $109,726,000 | +133.8% | 1,310,000 | 0.0% | 3.25% | +54.7% | |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $102,909,000 | +68.0% | 2,375,000 | +35.7% | 3.05% | +11.2% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $101,377,000 | +12.3% | 780,000 | +25.8% | 3.00% | -25.7% |
| CDXS | Buy | CODEXIS INC | $94,524,000 | +102.0% | 4,330,000 | +8.7% | 2.80% | +33.7% |
| SRPT | SAREPTA THERAPEUTICS INC | $90,360,000 | +21.4% | 530,000 | 0.0% | 2.68% | -19.7% | |
| CDNA | CAREDX INC | $86,457,000 | +91.0% | 1,193,335 | 0.0% | 2.56% | +26.3% | |
| RVMD | REVOLUTION MEDICINES INC | $64,711,000 | +13.8% | 1,634,535 | 0.0% | 1.92% | -24.7% | |
| CNST | Buy | CONSTELLATION PHARMCETICLS I | $51,408,000 | +158.9% | 1,785,000 | +82.1% | 1.52% | +71.3% |
| GBIO | GENERATION BIO CO | $45,678,000 | -8.3% | 1,611,214 | 0.0% | 1.35% | -39.3% | |
| Sell | DERMTECH INC | $44,443,000 | +160.3% | 1,370,000 | -4.1% | 1.32% | +72.4% | |
| BNR | BURNING ROCK BIOTECH LTDsponsored ads | $44,402,000 | -7.9% | 1,922,150 | 0.0% | 1.32% | -39.1% | |
| ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $42,167,000 | +21.6% | 713,125 | 0.0% | 1.25% | -19.6% | |
| CRSP | CRISPR THERAPEUTICS AGnamen akt | $40,793,000 | +83.1% | 266,430 | 0.0% | 1.21% | +21.1% | |
| BLUE | BLUEBIRD BIO INC | $39,592,000 | -19.8% | 915,000 | 0.0% | 1.17% | -46.9% | |
| ADVM | Buy | ADVERUM BIOTECHNOLOGIES INC | $39,566,000 | +39.7% | 3,650,000 | +32.7% | 1.17% | -7.6% |
| BGNE | BEIGENE LTDsponsored adr | $38,759,000 | -9.8% | 150,000 | 0.0% | 1.15% | -40.3% | |
| BEAM | New | BEAM THERAPEUTICS INC | $37,554,000 | – | 460,000 | +100.0% | 1.11% | – |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $35,081,000 | +61.1% | 810,000 | +105.1% | 1.04% | +6.6% |
| FDMT | New | 4D MOLECULAR THERAPEUTICS IN | $32,354,000 | – | 780,555 | +100.0% | 0.96% | – |
| MGTA | MAGENTA THERAPEUTICS INC | $26,233,000 | +15.3% | 3,346,034 | 0.0% | 0.78% | -23.7% | |
| ZLAB | ZAI LAB LTDadr | $25,715,000 | +62.7% | 190,000 | 0.0% | 0.76% | +7.6% | |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $25,520,000 | +167.3% | 550,000 | +89.7% | 0.76% | +77.0% |
| ALEC | ALECTOR INC | $24,965,000 | +43.6% | 1,650,000 | 0.0% | 0.74% | -4.9% | |
| ALLO | ALLOGENE THERAPEUTICS INC | $23,852,000 | -33.1% | 945,000 | 0.0% | 0.71% | -55.7% | |
| MASS | New | 908 DEVICES INC | $23,150,000 | – | 406,502 | +100.0% | 0.69% | – |
| TSHA | TAYSHA GENE THERAPIES INC | $21,774,000 | +18.5% | 820,440 | 0.0% | 0.64% | -21.6% | |
| ORIC | Buy | ORIC PHARMACEUTICALS INC | $20,361,000 | +223.7% | 601,515 | +139.2% | 0.60% | +113.8% |
| BLI | BERKELEY LTS INC | $17,882,000 | +17.1% | 200,000 | 0.0% | 0.53% | -22.5% | |
| KRON | New | KRONOS BIO INC | $17,427,000 | – | 583,436 | +100.0% | 0.52% | – |
| SGMO | SANGAMO THERAPEUTICS INC | $16,853,000 | +65.1% | 1,080,000 | 0.0% | 0.50% | +9.2% | |
| FULC | Sell | FULCRUM THERAPEUTICS INC | $14,534,000 | +27.2% | 1,241,176 | -13.9% | 0.43% | -15.8% |
| AMRS | New | AMYRIS INCcall | $12,350,000 | – | 2,000,000 | +100.0% | 0.37% | – |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $10,008,000 | – | 450,000 | +100.0% | 0.30% | – |
| BDTX | BLACK DIAMOND THERAPEUTICS I | $9,275,000 | +6.0% | 289,395 | 0.0% | 0.28% | -29.8% | |
| TPTX | TURNING POINT THERAPEUTICS I | $9,139,000 | +39.5% | 75,000 | 0.0% | 0.27% | -7.5% | |
| SEER | New | SEER INC | $8,421,000 | – | 150,000 | +100.0% | 0.25% | – |
| ABCL | New | ABCELLERA BIOLOGICS INC | $8,048,000 | – | 200,000 | +100.0% | 0.24% | – |
| DYN | DYNE THERAPEUTICS INC | $7,770,000 | +4.0% | 370,000 | 0.0% | 0.23% | -31.1% | |
| STOK | STOKE THERAPEUTICS INC | $7,432,000 | +84.9% | 120,000 | 0.0% | 0.22% | +22.2% | |
| FHTX | New | FOGHORN THERAPEUTICS INC | $4,383,000 | – | 216,216 | +100.0% | 0.13% | – |
| BMYRT | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $4,313,000 | -69.3% | 6,250,000 | 0.0% | 0.13% | -79.7% | |
| CDAK | New | CODIAK BIOSCIENCES INC | $2,477,000 | – | 76,688 | +100.0% | 0.07% | – |
| GBT | New | GLOBAL BLOOD THERAPEUTICS INcall | $2,166,000 | – | 50,000 | +100.0% | 0.06% | – |
| CCCC | New | C4 THERAPEUTICS INC | $1,325,000 | – | 40,000 | +100.0% | 0.04% | – |
| DCPH | Exit | DECIPHERA PHARMACEUTICALS IN | $0 | – | -65,000 | -100.0% | -0.15% | – |
| LEGN | Exit | LEGEND BIOTECH CORPsponsored ads | $0 | – | -139,661 | -100.0% | -0.19% | – |
| ORTX | Exit | ORCHARD THERAPEUTICS PLCads | $0 | – | -1,870,000 | -100.0% | -0.34% | – |
| ILMN | Exit | ILLUMINA INC | $0 | – | -30,000 | -100.0% | -0.42% | – |
| AMRS | Exit | AMYRIS INC | $0 | – | -7,390,000 | -100.0% | -0.97% | – |
| MYOK | Exit | MYOKARDIA INC | $0 | – | -870,000 | -100.0% | -5.31% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BLUEPRINT MEDICINES CORP | 32 | Q3 2023 | 9.6% |
| ALNYLAM PHARMACEUTICALS INC | 32 | Q3 2023 | 9.9% |
| AGIOS PHARMACEUTICALS INC | 27 | Q2 2022 | 12.1% |
| GLOBAL BLOOD THERAPEUTICS IN | 27 | Q2 2022 | 7.1% |
| FATE THERAPEUTICS INC | 26 | Q3 2023 | 8.3% |
| BIOLIFE SOLUTIONS INC | 22 | Q3 2023 | 14.9% |
| CODEXIS INC | 22 | Q3 2023 | 8.1% |
| SAREPTA THERAPEUTICS INC | 21 | Q3 2023 | 13.6% |
| BLUEBIRD BIO INC | 21 | Q4 2020 | 7.8% |
| ILLUMINA INC | 21 | Q3 2023 | 6.0% |
View Casdin Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Absci Corp | May 08, 2023 | 4,448,260 | 4.8% |
| CODEXIS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| DermTech, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Invitae Corp | February 14, 2023 | 9,038,388 | 3.7% |
| Magenta Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Tango Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Verve Therapeutics, Inc. | February 14, 2023 | 2,290,571 | 3.7% |
| Tenaya Therapeutics, Inc. | December 07, 2022 | 6,427,200 | 9.9% |
| Fulcrum Therapeutics, Inc. | February 11, 2021 | 1,241,176 | 4.5% |
| Gritstone Oncology, Inc.Sold out | February 11, 2021 | 0 | 0.0% |
View Casdin Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-18 |
| SC 13D/A | 2024-04-08 |
| 4 | 2024-03-28 |
| 3 | 2024-03-25 |
| 4 | 2024-03-25 |
| 4 | 2024-03-20 |
| SC 13D/A | 2024-03-20 |
| 4 | 2024-03-06 |
| 4 | 2024-03-06 |
| 13F-HR | 2024-02-14 |
View Casdin Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.